|
US3773919A
(en)
*
|
1969-10-23 |
1973-11-20 |
Du Pont |
Polylactide-drug mixtures
|
|
US4263428A
(en)
|
1978-03-24 |
1981-04-21 |
The Regents Of The University Of California |
Bis-anthracycline nucleic acid function inhibitors and improved method for administering the same
|
|
US4289872A
(en)
*
|
1979-04-06 |
1981-09-15 |
Allied Corporation |
Macromolecular highly branched homogeneous compound based on lysine units
|
|
ZA811368B
(en)
|
1980-03-24 |
1982-04-28 |
Genentech Inc |
Bacterial polypedtide expression employing tryptophan promoter-operator
|
|
EP0052322B1
(en)
|
1980-11-10 |
1985-03-27 |
Gersonde, Klaus, Prof. Dr. |
Method of preparing lipid vesicles by ultrasonic treatment, the use of this method and apparatus for its application
|
|
IE52535B1
(en)
|
1981-02-16 |
1987-12-09 |
Ici Plc |
Continuous release pharmaceutical compositions
|
|
FR2504010B1
(en)
|
1981-04-15 |
1985-10-25 |
Sanofi Sa |
ANTI-CANCER MEDICINAL PRODUCTS CONTAINING THE RICIN-ASSOCIATED CHAIN ASSOCIATED WITH ANTIMELANOMA ANTIBODY AND PROCESS FOR THEIR PREPARATION
|
|
US4551433A
(en)
|
1981-05-18 |
1985-11-05 |
Genentech, Inc. |
Microbial hybrid promoters
|
|
JPS57206622A
(en)
|
1981-06-10 |
1982-12-18 |
Ajinomoto Co Inc |
Blood substitute
|
|
US4485045A
(en)
*
|
1981-07-06 |
1984-11-27 |
Research Corporation |
Synthetic phosphatidyl cholines useful in forming liposomes
|
|
NZ201705A
(en)
|
1981-08-31 |
1986-03-14 |
Genentech Inc |
Recombinant dna method for production of hepatitis b surface antigen in yeast
|
|
EP0088046B1
(en)
*
|
1982-02-17 |
1987-12-09 |
Ciba-Geigy Ag |
Lipids in the aqueous phase
|
|
US4671958A
(en)
|
1982-03-09 |
1987-06-09 |
Cytogen Corporation |
Antibody conjugates for the delivery of compounds to target sites
|
|
DE3218121A1
(en)
|
1982-05-14 |
1983-11-17 |
Leskovar, Peter, Dr.-Ing., 8000 München |
Pharmaceutical compositions for tumour treatment
|
|
EP0102324A3
(en)
|
1982-07-29 |
1984-11-07 |
Ciba-Geigy Ag |
Lipids and surfactants in an aqueous medium
|
|
US4512922A
(en)
|
1982-12-22 |
1985-04-23 |
Genentech, Inc. |
Purification and activity assurance of precipitated heterologous proteins
|
|
US4511503A
(en)
|
1982-12-22 |
1985-04-16 |
Genentech, Inc. |
Purification and activity assurance of precipitated heterologous proteins
|
|
US4511502A
(en)
|
1982-12-22 |
1985-04-16 |
Genentech, Inc. |
Purification and activity assurance of precipitated heterologous proteins
|
|
CA1341302C
(en)
|
1983-02-22 |
2001-10-09 |
Rae Lyn Burke |
Yeast expression systems with vectors having gapdh or pyk promoters and synthesis of foreign protein
|
|
US5089398A
(en)
|
1983-02-22 |
1992-02-18 |
Chiron Corporation |
Enhanced yeast transcription employing hybrid GAPDH promoter region constructs
|
|
US4876197A
(en)
*
|
1983-02-22 |
1989-10-24 |
Chiron Corporation |
Eukaryotic regulatable transcription
|
|
JPS59166086A
(en)
|
1983-03-09 |
1984-09-19 |
Teruhiko Beppu |
Novel development type plasmid and development of vitular prochymosin gene in escherichia coli using it
|
|
US4859600A
(en)
*
|
1983-04-25 |
1989-08-22 |
Genentech, Inc. |
Recombinant procaryotic cell containing correctly processed human growth hormone
|
|
US4755465A
(en)
*
|
1983-04-25 |
1988-07-05 |
Genentech, Inc. |
Secretion of correctly processed human growth hormone in E. coli and Pseudomonas
|
|
EP0127839B1
(en)
|
1983-05-27 |
1992-07-15 |
THE TEXAS A&M UNIVERSITY SYSTEM |
Method for producing a recombinant baculovirus expression vector
|
|
US4544545A
(en)
*
|
1983-06-20 |
1985-10-01 |
Trustees University Of Massachusetts |
Liposomes containing modified cholesterol for organ targeting
|
|
GB8317880D0
(en)
|
1983-07-01 |
1983-08-03 |
Searle & Co |
Structure and synthesis of interferons
|
|
HUT35524A
(en)
|
1983-08-02 |
1985-07-29 |
Hoechst Ag |
Process for preparing pharmaceutical compositions containing regulatory /regulative/ peptides providing for the retarded release of the active substance
|
|
US4689406A
(en)
*
|
1983-08-10 |
1987-08-25 |
Amgen |
Enhancement of microbial expression of polypeptides
|
|
US4870008A
(en)
|
1983-08-12 |
1989-09-26 |
Chiron Corporation |
Secretory expression in eukaryotes
|
|
ATE59966T1
(en)
*
|
1983-09-26 |
1991-02-15 |
Ehrenfeld Udo |
MEDICATION AND PRODUCT FOR THE DIAGNOSIS AND THERAPY OF TUMORS AND FOR THE TREATMENT OF WEAKNESSES IN THE CELLULAR AND HUMORAL IMMUNE DEFENSE.
|
|
US4615885A
(en)
|
1983-11-01 |
1986-10-07 |
Terumo Kabushiki Kaisha |
Pharmaceutical composition containing urokinase
|
|
ZA848495B
(en)
|
1984-01-31 |
1985-09-25 |
Idaho Res Found |
Production of polypeptides in insect cells
|
|
DE3572982D1
(en)
|
1984-03-06 |
1989-10-19 |
Takeda Chemical Industries Ltd |
Chemically modified lymphokine and production thereof
|
|
DE3587759T2
(en)
|
1984-05-11 |
1994-07-07 |
Chiron Corp., Emeryville, Calif. |
Increased yeast transcription using a hybrid construction of the promoter region.
|
|
US4880734A
(en)
|
1984-05-11 |
1989-11-14 |
Chiron Corporation |
Eukaryotic regulatable transcription
|
|
GB8412564D0
(en)
|
1984-05-17 |
1984-06-20 |
Searle & Co |
Structure and properties
|
|
US4931373A
(en)
|
1984-05-25 |
1990-06-05 |
Zymogenetics, Inc. |
Stable DNA constructs for expression of α-1 antitrypsin
|
|
US4542225A
(en)
|
1984-08-29 |
1985-09-17 |
Dana-Farber Cancer Institute, Inc. |
Acid-cleavable compound
|
|
US4738921A
(en)
|
1984-09-27 |
1988-04-19 |
Eli Lilly And Company |
Derivative of the tryptophan operon for expression of fused gene products
|
|
US4659839A
(en)
|
1984-10-10 |
1987-04-21 |
Mallinckrodt, Inc. |
Coupling agents for radiolabeled antibody fragments
|
|
US4837148A
(en)
*
|
1984-10-30 |
1989-06-06 |
Phillips Petroleum Company |
Autonomous replication sequences for yeast strains of the genus pichia
|
|
GB8430252D0
(en)
|
1984-11-30 |
1985-01-09 |
Beecham Group Plc |
Compounds
|
|
ATE66469T1
(en)
|
1985-01-14 |
1991-09-15 |
Neorx Corp |
METAL RADIONUCLIDE LABELED PROTEIN FOR DIAGNOSIS AND THERAPY.
|
|
US4751180A
(en)
|
1985-03-28 |
1988-06-14 |
Chiron Corporation |
Expression using fused genes providing for protein product
|
|
EP0206448B1
(en)
|
1985-06-19 |
1990-11-14 |
Ajinomoto Co., Inc. |
Hemoglobin combined with a poly(alkylene oxide)
|
|
EP0229108B1
(en)
|
1985-06-26 |
1990-12-27 |
Cetus Corporation |
Solubilization of proteins for pharmaceutical compositions using polymer conjugation
|
|
PH25772A
(en)
|
1985-08-30 |
1991-10-18 |
Novo Industri As |
Insulin analogues, process for their preparation
|
|
US4680338A
(en)
*
|
1985-10-17 |
1987-07-14 |
Immunomedics, Inc. |
Bifunctional linker
|
|
WO1987002670A1
(en)
|
1985-10-25 |
1987-05-07 |
Mackay Vivian L |
Method of using bar1 for secreting foreign proteins
|
|
US4699784A
(en)
|
1986-02-25 |
1987-10-13 |
Center For Molecular Medicine & Immunology |
Tumoricidal methotrexate-antibody conjugate
|
|
GB8610600D0
(en)
|
1986-04-30 |
1986-06-04 |
Novo Industri As |
Transformation of trichoderma
|
|
JPS63123383A
(en)
|
1986-11-11 |
1988-05-27 |
Mitsubishi Kasei Corp |
Hybrid promoter, manifestation regulating dna sequence and manifestation vector
|
|
US5186933A
(en)
|
1986-12-30 |
1993-02-16 |
Baylor College Of Medicine |
Synthesis and immunogenicity of rotavirus genes using a baculovirus expression system
|
|
EP0349594A4
(en)
|
1987-03-16 |
1990-09-26 |
American Biogenetic Sciences, Inc. |
Recombinant baculovirus occlusion bodies in vaccines and biological insecticides
|
|
ATE103333T1
(en)
|
1987-03-23 |
1994-04-15 |
Zymogenetics Inc |
HIGH PROTEIN SYNTHESIS RATE IN YEAST.
|
|
US5229490A
(en)
*
|
1987-05-06 |
1993-07-20 |
The Rockefeller University |
Multiple antigen peptide system
|
|
WO1989001037A1
(en)
|
1987-07-24 |
1989-02-09 |
Cetus Corporation |
Production of ricin toxins in a baculovirus-insect cell expression system
|
|
AU2251488A
(en)
|
1987-07-24 |
1989-03-01 |
Cetus Corporation |
Production of biologically active forms of csf using a baculovirus (acnpv)-insect cell expression system
|
|
US5080891A
(en)
*
|
1987-08-03 |
1992-01-14 |
Ddi Pharmaceuticals, Inc. |
Conjugates of superoxide dismutase coupled to high molecular weight polyalkylene glycols
|
|
US4929555A
(en)
|
1987-10-19 |
1990-05-29 |
Phillips Petroleum Company |
Pichia transformation
|
|
GB8725529D0
(en)
|
1987-10-30 |
1987-12-02 |
Delta Biotechnology Ltd |
Polypeptides
|
|
US4904584A
(en)
*
|
1987-12-23 |
1990-02-27 |
Genetics Institute, Inc. |
Site-specific homogeneous modification of polypeptides
|
|
CA1340772C
(en)
|
1987-12-30 |
1999-09-28 |
Patricia Tekamp-Olson |
Expression and secretion of heterologous protiens in yeast employing truncated alpha-factor leader sequences
|
|
US4847325A
(en)
|
1988-01-20 |
1989-07-11 |
Cetus Corporation |
Conjugation of polymer to colony stimulating factor-1
|
|
JPH01254699A
(en)
|
1988-04-05 |
1989-10-11 |
Kodama Kk |
Insulin derivative and use thereof
|
|
US5674706A
(en)
|
1988-05-06 |
1997-10-07 |
Chiron Corporation |
High level expression of proteins in yeast
|
|
CA1324969C
(en)
|
1988-05-06 |
1993-12-07 |
Jeffrey R. Shuster |
High level expression of proteins in yeast
|
|
FR2631974B1
(en)
|
1988-05-31 |
1992-12-11 |
Agronomique Inst Nat Rech |
MODIFIED BACULOVIRUS, ITS PREPARATION METHOD AND ITS APPLICATION AS A GENE EXPRESSION VECTOR
|
|
WO1990001556A1
(en)
|
1988-08-05 |
1990-02-22 |
Mount Sinai School Of Medicine Of The City University Of New York |
In vivo infection of live insects with a recombinant baculovirus
|
|
GB8819453D0
(en)
|
1988-08-16 |
1988-09-21 |
Roy P |
Production of bluetongue virus non-structural proteins using baculovirus expression vector
|
|
NZ230425A
(en)
|
1988-09-02 |
1992-07-28 |
Molecular Eng Ass |
Production of paramyxovirus fusion (f) protein using recombinant baculovirus expression vector
|
|
GB8824591D0
(en)
|
1988-10-20 |
1988-11-23 |
Royal Free Hosp School Med |
Fractionation process
|
|
US6780613B1
(en)
|
1988-10-28 |
2004-08-24 |
Genentech, Inc. |
Growth hormone variants
|
|
WO1990004788A1
(en)
|
1988-10-28 |
1990-05-03 |
Genentech, Inc. |
Method for identifying active domains and amino acid residues in polypeptides and hormone variants
|
|
AU649217B2
(en)
|
1988-11-18 |
1994-05-19 |
Regents Of The University Of California, The |
Method for site-specifically incorporating unnatural amino acids into proteins
|
|
US5047335A
(en)
|
1988-12-21 |
1991-09-10 |
The Regents Of The University Of Calif. |
Process for controlling intracellular glycosylation of proteins
|
|
ATE135370T1
(en)
|
1988-12-22 |
1996-03-15 |
Kirin Amgen Inc |
CHEMICALLY MODIFIED GRANULOCYTE COLONY EXCITING FACTOR
|
|
AU641631B2
(en)
|
1988-12-23 |
1993-09-30 |
Novo Nordisk A/S |
Human insulin analogues
|
|
US4902502A
(en)
|
1989-01-23 |
1990-02-20 |
Cetus Corporation |
Preparation of a polymer/interleukin-2 conjugate
|
|
US5514646A
(en)
|
1989-02-09 |
1996-05-07 |
Chance; Ronald E. |
Insulin analogs modified at position 29 of the B chain
|
|
AU5187190A
(en)
|
1989-02-23 |
1990-09-26 |
University Of Ottawa |
Improved baculovirus expression system capable of producing foreign gene proteins at high levels
|
|
WO1990010277A1
(en)
|
1989-02-24 |
1990-09-07 |
Cell Analysis Systems, Inc. |
Method and apparatus for determining a proliferation index of a cell sample
|
|
US5324844A
(en)
*
|
1989-04-19 |
1994-06-28 |
Enzon, Inc. |
Active carbonates of polyalkylene oxides for modification of polypeptides
|
|
US5122614A
(en)
|
1989-04-19 |
1992-06-16 |
Enzon, Inc. |
Active carbonates of polyalkylene oxides for modification of polypeptides
|
|
ES2247656T3
(en)
|
1989-04-19 |
2006-03-01 |
Enzon, Inc. |
A PROCESS TO FORM A MODIFIED POLYPEPTIDE THAT INCLUDES A POLYPEPTIDE AND A POLYCHYLENE OXIDE.
|
|
US5766883A
(en)
|
1989-04-29 |
1998-06-16 |
Delta Biotechnology Limited |
Polypeptides
|
|
ATE92107T1
(en)
|
1989-04-29 |
1993-08-15 |
Delta Biotechnology Ltd |
N-TERMINAL FRAGMENTS OF HUMAN SERUM ALBUMIN-CONTAINING FUSION PROTEINS.
|
|
AU631223B2
(en)
|
1989-05-17 |
1992-11-19 |
University Of Georgia Research Foundation, Inc., The |
Improved baculovirus expression vectors
|
|
EP0400472B1
(en)
|
1989-05-27 |
1996-04-03 |
Sumitomo Pharmaceuticals Company, Limited |
Process for preparing polyethylene glycol derivatives and modified protein.
|
|
FR2649120B1
(en)
|
1989-06-30 |
1994-01-28 |
Cayla |
NOVEL STRAIN AND ITS MUTANTS OF FILAMENTOUS MUSHROOMS, PROCESS FOR PRODUCING RECOMBINANT PROTEINS USING SAID STRAIN, AND STRAINS AND PROTEINS OBTAINED BY SAID METHOD
|
|
US5312808A
(en)
|
1989-11-22 |
1994-05-17 |
Enzon, Inc. |
Fractionation of polyalkylene oxide-conjugated hemoglobin solutions
|
|
US5162601A
(en)
*
|
1989-11-22 |
1992-11-10 |
The Upjohn Company |
Plant potyvirus expression vector with a gene for protease
|
|
US5219564A
(en)
|
1990-07-06 |
1993-06-15 |
Enzon, Inc. |
Poly(alkylene oxide) amino acid copolymers and drug carriers and charged copolymers based thereon
|
|
FR2664905B1
(en)
|
1990-07-18 |
1994-08-12 |
Agronomique Inst Nat Rech |
MODIFIED BACULOVIRUS, PROCESS FOR OBTAINING SAME, AND EXPRESSION VECTORS OBTAINED FROM SAID BACULOVIRUS.
|
|
WO1992001800A1
(en)
|
1990-07-20 |
1992-02-06 |
Chiron Corporation |
Method for integrative transformation of yeast using dispersed repetitive elements
|
|
WO1992002628A1
(en)
|
1990-08-02 |
1992-02-20 |
Chiron Corporation |
Expression of human cmv glycoprotein-h using the baculovirus-insect cell expression system
|
|
JPH06500470A
(en)
|
1990-09-04 |
1994-01-20 |
メルク エンド カンパニー インコーポレーテッド |
Production of insulin-like growth factors in methylotrophic yeast cells
|
|
US5492821A
(en)
|
1990-11-14 |
1996-02-20 |
Cargill, Inc. |
Stabilized polyacrylic saccharide protein conjugates
|
|
US5252714A
(en)
|
1990-11-28 |
1993-10-12 |
The University Of Alabama In Huntsville |
Preparation and use of polyethylene glycol propionaldehyde
|
|
DK0564531T3
(en)
|
1990-12-03 |
1998-09-28 |
Genentech Inc |
Enrichment procedure for variant proteins with altered binding properties
|
|
US5231178A
(en)
|
1991-01-16 |
1993-07-27 |
The Salk Institute Biotechnology/Industrial Associates, Inc. |
Method for the purification of intact, correctly-folded insulin-like growth factor-1
|
|
WO1992016555A1
(en)
|
1991-03-18 |
1992-10-01 |
Enzon, Inc. |
Hydrazine containing conjugates of polypeptides and glycopolypeptides with polymers
|
|
WO1992016619A1
(en)
|
1991-03-19 |
1992-10-01 |
Us Army |
Expression of influenza nucleoprotein antigens in baculovirus
|
|
US5595732A
(en)
|
1991-03-25 |
1997-01-21 |
Hoffmann-La Roche Inc. |
Polyethylene-protein conjugates
|
|
US6013433A
(en)
|
1991-04-26 |
2000-01-11 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Baculovirus expression vectors and recombinant antigens for detecting type-specific antibodies to herpes simplex virus
|
|
US5281698A
(en)
|
1991-07-23 |
1994-01-25 |
Cetus Oncology Corporation |
Preparation of an activated polymer ester for protein conjugation
|
|
US5290686A
(en)
*
|
1991-07-31 |
1994-03-01 |
The United States Of America As Represented By The Department Of Health And Human Services |
Expression of influenza a M2 protein in baculovirus
|
|
IT1260468B
(en)
|
1992-01-29 |
1996-04-09 |
|
METHOD FOR MAINTAINING THE ACTIVITY OF PROTEOLYTIC ENZYMES MODIFIED WITH POLYETHYLENGLYCOL
|
|
FR2686899B1
(en)
|
1992-01-31 |
1995-09-01 |
Rhone Poulenc Rorer Sa |
NOVEL BIOLOGICALLY ACTIVE POLYPEPTIDES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
|
|
ATE156158T1
(en)
|
1992-04-14 |
1997-08-15 |
Cornell Res Foundation Inc |
MACROMOLECULES BASED ON DENDRITIC POLYMERS AND METHOD FOR THE PRODUCTION
|
|
US5516657A
(en)
*
|
1992-05-11 |
1996-05-14 |
Cambridge Biotech Corporation |
Baculovirus vectors for expression of secretory and membrane-bound proteins
|
|
ZA933926B
(en)
|
1992-06-17 |
1994-01-03 |
Amgen Inc |
Polyoxymethylene-oxyethylene copolymers in conjuction with blomolecules
|
|
WO1994004193A1
(en)
|
1992-08-21 |
1994-03-03 |
Enzon, Inc. |
Novel attachment of polyalkylene oxides to bio-effecting substances
|
|
US5382657A
(en)
|
1992-08-26 |
1995-01-17 |
Hoffmann-La Roche Inc. |
Peg-interferon conjugates
|
|
NZ250375A
(en)
|
1992-12-09 |
1995-07-26 |
Ortho Pharma Corp |
Peg hydrazone and peg oxime linkage forming reagents and protein derivatives
|
|
US5298643A
(en)
|
1992-12-22 |
1994-03-29 |
Enzon, Inc. |
Aryl imidate activated polyalkylene oxides
|
|
AU6029594A
(en)
|
1993-01-15 |
1994-08-15 |
Enzon, Inc. |
Factor viii - polymeric conjugates
|
|
US5349001A
(en)
|
1993-01-19 |
1994-09-20 |
Enzon, Inc. |
Cyclic imide thione activated polyalkylene oxides
|
|
US5321095A
(en)
|
1993-02-02 |
1994-06-14 |
Enzon, Inc. |
Azlactone activated polyalkylene oxides
|
|
US5532142A
(en)
*
|
1993-02-12 |
1996-07-02 |
Board Of Regents, The University Of Texas System |
Method of isolation and purification of fusion polypeptides
|
|
IL104734A0
(en)
*
|
1993-02-15 |
1993-06-10 |
Univ Bar Ilan |
Bioactive conjugates of cellulose with amino compounds
|
|
WO1994028024A1
(en)
|
1993-06-01 |
1994-12-08 |
Enzon, Inc. |
Carbohydrate-modified polymer conjugates with erythropoietic activity
|
|
WO1995000162A1
(en)
|
1993-06-21 |
1995-01-05 |
Enzon, Inc. |
Site specific synthesis of conjugated peptides
|
|
GB9317618D0
(en)
|
1993-08-24 |
1993-10-06 |
Royal Free Hosp School Med |
Polymer modifications
|
|
US5762939A
(en)
|
1993-09-13 |
1998-06-09 |
Mg-Pmc, Llc |
Method for producing influenza hemagglutinin multivalent vaccines using baculovirus
|
|
US5919455A
(en)
|
1993-10-27 |
1999-07-06 |
Enzon, Inc. |
Non-antigenic branched polymer conjugates
|
|
US5643575A
(en)
|
1993-10-27 |
1997-07-01 |
Enzon, Inc. |
Non-antigenic branched polymer conjugates
|
|
US5491076A
(en)
*
|
1993-11-01 |
1996-02-13 |
The Texas A&M University System |
Expression of foreign genes using a replicating polyprotein producing virus vector
|
|
US5605792A
(en)
|
1993-11-04 |
1997-02-25 |
The Ohio State University Research Foundation |
Infectious bursal disease virus VP2 fusion protein expressed by baculovirus, use as diagnostic
|
|
US5951974A
(en)
|
1993-11-10 |
1999-09-14 |
Enzon, Inc. |
Interferon polymer conjugates
|
|
NZ276943A
(en)
|
1993-11-10 |
1998-02-26 |
Schering Corp Substituted For |
Alpha-interferon conjugated to a non-antigenic polymer (preferably a polyalkylene oxide) and its preparation
|
|
US5446090A
(en)
|
1993-11-12 |
1995-08-29 |
Shearwater Polymers, Inc. |
Isolatable, water soluble, and hydrolytically stable active sulfones of poly(ethylene glycol) and related polymers for modification of surfaces and molecules
|
|
WO1995016708A1
(en)
|
1993-12-17 |
1995-06-22 |
Novo Nordisk A/S |
Proinsulin-like compounds
|
|
FR2715664B1
(en)
|
1994-01-31 |
1996-04-12 |
Proteine Performance Sa |
Recombinant baculovirus and its use for the production of monoclonal antibodies.
|
|
JP3090586B2
(en)
|
1994-03-15 |
2000-09-25 |
片倉工業株式会社 |
Baculovirus deficient in cysteine protease gene, method for producing the same, and method for producing useful protein using the same
|
|
US5473034A
(en)
|
1994-03-18 |
1995-12-05 |
Hyogo Prefectural Government |
Method for producing protein-synthetic polymer conjugate and said conjugate produced thereby
|
|
US5629384A
(en)
|
1994-05-17 |
1997-05-13 |
Consiglio Nazionale Delle Ricerche |
Polymers of N-acryloylmorpholine activated at one end and conjugates with bioactive materials and surfaces
|
|
WO1995033490A1
(en)
|
1994-06-02 |
1995-12-14 |
Enzon, Inc. |
Method of solubilizing substantially water insoluble materials
|
|
US5730990A
(en)
|
1994-06-24 |
1998-03-24 |
Enzon, Inc. |
Non-antigenic amine derived polymers and polymer conjugates
|
|
US6403375B1
(en)
|
1994-08-24 |
2002-06-11 |
Boyce Thompson Institute For Plant Research, Inc. |
Establishment of Trichoplusia ni cell lines in serum-free medium for recombinant protein and baculovirus production
|
|
US5650234A
(en)
*
|
1994-09-09 |
1997-07-22 |
Surface Engineering Technologies, Division Of Innerdyne, Inc. |
Electrophilic polyethylene oxides for the modification of polysaccharides, polypeptides (proteins) and surfaces
|
|
US5871986A
(en)
|
1994-09-23 |
1999-02-16 |
The General Hospital Corporation |
Use of a baculovirus to express and exogenous gene in a mammalian cell
|
|
US5824784A
(en)
|
1994-10-12 |
1998-10-20 |
Amgen Inc. |
N-terminally chemically modified protein compositions and methods
|
|
CA2204726A1
(en)
|
1994-11-09 |
1996-12-27 |
Robin E. Offord |
Functionalized polymers for site-specific attachment
|
|
US5738846A
(en)
|
1994-11-10 |
1998-04-14 |
Enzon, Inc. |
Interferon polymer conjugates and process for preparing the same
|
|
US5932462A
(en)
*
|
1995-01-10 |
1999-08-03 |
Shearwater Polymers, Inc. |
Multiarmed, monofunctional, polymer for coupling to molecules and surfaces
|
|
KR0150565B1
(en)
|
1995-02-15 |
1998-08-17 |
김정재 |
A process for preparing human proinsulin by recombinant dna technology
|
|
US6183987B1
(en)
|
1995-02-17 |
2001-02-06 |
Stichting Institut Voor Dierhouderij En Diergezonheld |
Production of biologically active recombinant bovine follicle stimulation hormone (rec bFSH) in the baculovirus expression system
|
|
FR2732035B1
(en)
|
1995-03-23 |
1997-05-30 |
Agronomique Inst Nat Rech |
METHOD FOR REGULATING THE EXPRESSION OF A GENE IN A BACULOVIRUS, BY A FIXATION SITE OF A RETINOIC ACID RECEPTOR, AND VECTOR FOR CARRYING OUT SAID METHOD
|
|
US6184344B1
(en)
|
1995-05-04 |
2001-02-06 |
The Scripps Research Institute |
Synthesis of proteins by native chemical ligation
|
|
CA2223272A1
(en)
|
1995-05-05 |
1996-11-07 |
Ronald Eugene Chance |
Single chain insulin with high bioactivity
|
|
NZ308772A
(en)
|
1995-05-17 |
1999-04-29 |
Du Pont |
Recombinant baculovirus insecticides
|
|
AU5893696A
(en)
|
1995-06-07 |
1996-12-30 |
Novo Nordisk A/S |
Modification of polypeptides
|
|
US20010041786A1
(en)
|
1995-06-07 |
2001-11-15 |
Mark L. Brader |
Stabilized acylated insulin formulations
|
|
US5833948A
(en)
|
1995-06-15 |
1998-11-10 |
Bracco Research S.A. |
Blood-pool imaging composition comprising micelles containing a lipophilic chelating agent and a non-ionic surfactant
|
|
US5672662A
(en)
*
|
1995-07-07 |
1997-09-30 |
Shearwater Polymers, Inc. |
Poly(ethylene glycol) and related polymers monosubstituted with propionic or butanoic acids and functional derivatives thereof for biotechnical applications
|
|
GB9526733D0
(en)
|
1995-12-30 |
1996-02-28 |
Delta Biotechnology Ltd |
Fusion proteins
|
|
US5861279A
(en)
|
1996-01-17 |
1999-01-19 |
Schering Corporation |
Baculovirus expression system for human interleukin 5 receptor and method of screening for interleukin 5 antagonists
|
|
AU1690697A
(en)
|
1996-01-17 |
1997-08-11 |
Schering Corporation |
Baculovirus expression system for human interleukin 5 receptor and method of screening for interleukin antagonists
|
|
US5747639A
(en)
|
1996-03-06 |
1998-05-05 |
Amgen Boulder Inc. |
Use of hydrophobic interaction chromatography to purify polyethylene glycols
|
|
TW517067B
(en)
|
1996-05-31 |
2003-01-11 |
Hoffmann La Roche |
Interferon conjugates
|
|
SI0964702T1
(en)
|
1996-08-02 |
2007-02-28 |
Ortho Mcneil Pharm Inc |
Polypeptides having a single covalently bound n-terminal water-soluble polymer
|
|
US5980948A
(en)
|
1996-08-16 |
1999-11-09 |
Osteotech, Inc. |
Polyetherester copolymers as drug delivery matrices
|
|
US6214966B1
(en)
*
|
1996-09-26 |
2001-04-10 |
Shearwater Corporation |
Soluble, degradable poly(ethylene glycol) derivatives for controllable release of bound molecules into solution
|
|
US5998595A
(en)
|
1996-11-05 |
1999-12-07 |
Wako Pure Chemical Industries, Ltd. |
Azidohalogenobenzyl derivatives, sugar compounds and protection of hydroxy groups
|
|
JP4341859B2
(en)
|
1996-12-13 |
2009-10-14 |
ノバルティス バクシンズ アンド ダイアグノスティックス， インコーポレーテッド |
Methods for the expression of heterologous proteins in yeast
|
|
JP2001508783A
(en)
|
1997-01-29 |
2001-07-03 |
ポリマスク・ファーマシューティカルズ・パブリック・リミテッド・カンパニー |
PEGylation method
|
|
GB9703406D0
(en)
|
1997-02-19 |
1997-04-09 |
Chiron Spa |
Expression of heterologous proteins
|
|
EP0974111B1
(en)
|
1997-04-11 |
2003-01-08 |
California Institute Of Technology |
Apparatus and method for automated protein design
|
|
EP0979102A4
(en)
|
1997-04-30 |
2005-11-23 |
Enzon Inc |
Polyalkylene oxide-modified single chain polypeptides
|
|
US5990237A
(en)
*
|
1997-05-21 |
1999-11-23 |
Shearwater Polymers, Inc. |
Poly(ethylene glycol) aldehyde hydrates and related polymers and applications in modifying amines
|
|
HUP0001153A3
(en)
|
1997-06-06 |
2000-12-28 |
Kyowa Hakko Kogyo Kk |
Chemically modified polypeptides, process for producing thereof, pharmaceutical compositions comprising these polypeptides and their use
|
|
DE19726167B4
(en)
|
1997-06-20 |
2008-01-24 |
Sanofi-Aventis Deutschland Gmbh |
Insulin, process for its preparation and pharmaceutical preparation containing it
|
|
US5965393A
(en)
*
|
1997-07-01 |
1999-10-12 |
National Institute Of Immunology |
Method for enhancing foreign gene expression in baculovirus expression vector system
|
|
ES2297889T3
(en)
|
1997-07-14 |
2008-05-01 |
Bolder Biotechnology, Inc. |
DERIVATIVES OF HORMONE OF GROWTH AND RELATED PROTEINS.
|
|
GB9715660D0
(en)
|
1997-07-25 |
1997-10-01 |
Zeneca Ltd |
Proteins
|
|
US6410264B1
(en)
|
1997-08-05 |
2002-06-25 |
Chiron Corporation |
Pichia pastoris gene sequences and methods for their use
|
|
DE19735593C2
(en)
|
1997-08-15 |
1999-08-26 |
Hepavec Ag Fuer Gentherapie |
Coat protein-modified baculovirus vector for gene therapy
|
|
US6090584A
(en)
|
1997-08-21 |
2000-07-18 |
University Technologies International Inc. |
Baculovirus artificial chromosomes and methods of use
|
|
US5989868A
(en)
*
|
1997-09-12 |
1999-11-23 |
The Board Of Regents Of The University Of Oklahoma |
Fusion protein systems designed to increase soluble cytoplasmic expression of heterologous proteins in esherichia coli
|
|
ES2340857T3
(en)
|
1997-09-16 |
2010-06-10 |
Centocor Ortho Biotech Inc. |
METHOD FOR COMPLETE CHEMICAL SYNTHESIS AND EXEMPTION OF GENES AND GENOMES.
|
|
WO1999016318A1
(en)
|
1997-09-26 |
1999-04-08 |
Uab Research Foundation |
Reduced antigenic cells and uses therefor
|
|
US6004573A
(en)
|
1997-10-03 |
1999-12-21 |
Macromed, Inc. |
Biodegradable low molecular weight triblock poly(lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
|
|
US6201072B1
(en)
|
1997-10-03 |
2001-03-13 |
Macromed, Inc. |
Biodegradable low molecular weight triblock poly(lactide-co- glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
|
|
DE19748489A1
(en)
|
1997-11-03 |
1999-05-06 |
Roche Diagnostics Gmbh |
Polyethylene glycol-derivatized biomolecules and their use in heterogeneous detection methods
|
|
US6448369B1
(en)
|
1997-11-06 |
2002-09-10 |
Shearwater Corporation |
Heterobifunctional poly(ethylene glycol) derivatives and methods for their preparation
|
|
EP0924298A1
(en)
|
1997-12-18 |
1999-06-23 |
Stichting Instituut voor Dierhouderij en Diergezondheid (ID-DLO) |
Protein expression in baculovirus vector expression systems
|
|
US5981709A
(en)
|
1997-12-19 |
1999-11-09 |
Enzon, Inc. |
α-interferon-polymer-conjugates having enhanced biological activity and methods of preparing the same
|
|
US5985263A
(en)
|
1997-12-19 |
1999-11-16 |
Enzon, Inc. |
Substantially pure histidine-linked protein polymer conjugates
|
|
JP2002505110A
(en)
|
1998-03-04 |
2002-02-19 |
オニックス ファーマシューティカルズ，インコーポレイティド |
Baculovirus expression systems and methods for highly productive expression of genetic material
|
|
US6423685B1
(en)
|
1998-03-05 |
2002-07-23 |
Chiron Corporation |
Method for increasing the serum half-life of a biologically active molecule
|
|
DK1061954T3
(en)
|
1998-03-12 |
2004-10-18 |
Nektar Therapeutics Al Corp |
Polyethylene glycol derivatives with proximal reactive groups
|
|
KR100264953B1
(en)
|
1998-04-03 |
2001-03-02 |
박현우 |
Recombinant baculovirus, process for preparing thereof and microbial insecticides containing same
|
|
US6451986B1
(en)
|
1998-06-22 |
2002-09-17 |
Immunex Corporation |
Site specific protein modification
|
|
US6168932B1
(en)
|
1998-07-13 |
2001-01-02 |
Parker Hughes Institute |
Recombinant DTctGMCSF fusion toxin in a baculovirus expression vector system
|
|
US6245528B1
(en)
|
1998-07-28 |
2001-06-12 |
Academia Sinica |
Latent baculovirus expression system
|
|
US6368825B1
(en)
|
1998-08-10 |
2002-04-09 |
Academia Sinica |
Baculovirus containing minimal CMV promoter
|
|
CN1330675A
(en)
|
1998-08-28 |
2002-01-09 |
格莱风科学公司 |
Polyamide chains of precise length, methods to manufacture them and their conjugates with protein
|
|
WO2000020032A1
(en)
|
1998-10-06 |
2000-04-13 |
Trustees Of Dartmouth College |
RECOMBINANT CAT ALLERGEN, Fel dI, EXPRESSED IN BACULOVIRUS FOR DIAGNOSIS AND TREATMENT OF CAT ALLERGY
|
|
US6420339B1
(en)
|
1998-10-14 |
2002-07-16 |
Amgen Inc. |
Site-directed dual pegylation of proteins for improved bioactivity and biocompatibility
|
|
US6403312B1
(en)
|
1998-10-16 |
2002-06-11 |
Xencor |
Protein design automatic for protein libraries
|
|
CN1325443A
(en)
|
1998-10-30 |
2001-12-05 |
诺沃奇梅兹有限公司 |
Glycosylated proteins having reduced allergenicity
|
|
US6451346B1
(en)
|
1998-12-23 |
2002-09-17 |
Amgen Inc |
Biodegradable pH/thermosensitive hydrogels for sustained delivery of biologically active agents
|
|
US6281211B1
(en)
|
1999-02-04 |
2001-08-28 |
Euro-Celtique S.A. |
Substituted semicarbazides and the use thereof
|
|
US6342216B1
(en)
|
1999-03-17 |
2002-01-29 |
The Board Of Regents, The University Of Texas System |
Therapy of cancer by insect cells containing recombinant baculovirus encoding genes
|
|
US6994986B2
(en)
|
1999-03-17 |
2006-02-07 |
The Board Of Trustees Of The Leland Stanford University |
In vitro synthesis of polypeptides by optimizing amino acid metabolism
|
|
CA2365668C
(en)
|
1999-03-17 |
2014-05-20 |
The Board Of Trustees Of The Leland Stanford Junior University |
In vitro macromolecule biosynthesis methods using exogenous amino acids and a novel atp regeneration system
|
|
US6337191B1
(en)
|
1999-03-22 |
2002-01-08 |
The Board Of Trustees Of The Leland Stanford Junior University |
Vitro protein synthesis using glycolytic intermediates as an energy source
|
|
EP1171006B1
(en)
|
1999-04-16 |
2006-03-29 |
Wm. MARSH RICE UNIVERSITY |
Functionalized poly(propylene fumarate) and poly(propylene fumarate-co-ethylene glycol)
|
|
US6261805B1
(en)
|
1999-07-15 |
2001-07-17 |
Boyce Thompson Institute For Plant Research, Inc. |
Sialyiation of N-linked glycoproteins in the baculovirus expression vector system
|
|
AU2039501A
(en)
|
1999-10-15 |
2001-04-23 |
Rockefeller University, The |
System for rapid generation of recombinant baculovirus-based expression vectors for silkworm larvae
|
|
US6348558B1
(en)
|
1999-12-10 |
2002-02-19 |
Shearwater Corporation |
Hydrolytically degradable polymers and hydrogels made therefrom
|
|
CA2394980C
(en)
|
1999-12-22 |
2008-05-13 |
Shearwater Corporation |
Sterically hindered derivatives of water soluble polymers
|
|
EP1259563B2
(en)
|
1999-12-22 |
2016-08-10 |
Nektar Therapeutics |
Method for the preparation of 1-benzotriazolyl carbonate esters of water soluble polymers.
|
|
US6413507B1
(en)
|
1999-12-23 |
2002-07-02 |
Shearwater Corporation |
Hydrolytically degradable carbamate derivatives of poly (ethylene glycol)
|
|
US6777207B2
(en)
|
1999-12-29 |
2004-08-17 |
Novo Nordisk A/S |
Method for making insulin precursors and insulin precursor analogues having improved fermentation yield in yeast
|
|
US6646110B2
(en)
|
2000-01-10 |
2003-11-11 |
Maxygen Holdings Ltd. |
G-CSF polypeptides and conjugates
|
|
AU2001238595A1
(en)
|
2000-02-22 |
2001-09-03 |
Shearwater Corporation |
N-maleimidyl polymer derivatives
|
|
AU2001257577A1
(en)
|
2000-02-28 |
2001-09-03 |
Shearwater Corporation |
Water-soluble polymer conjugates of artelinic acid
|
|
US6586207B2
(en)
|
2000-05-26 |
2003-07-01 |
California Institute Of Technology |
Overexpression of aminoacyl-tRNA synthetases for efficient production of engineered proteins containing amino acid analogues
|
|
GB0012997D0
(en)
|
2000-05-26 |
2000-07-19 |
Eurogene Limited |
Gene delivery
|
|
JP2002030098A
(en)
|
2000-07-17 |
2002-01-29 |
Institute Of Immunology Co Ltd |
Method for recovering virion envelope from budded virus of baculovirus
|
|
US7118737B2
(en)
*
|
2000-09-08 |
2006-10-10 |
Amylin Pharmaceuticals, Inc. |
Polymer-modified synthetic proteins
|
|
PL365671A1
(en)
|
2000-09-08 |
2005-01-10 |
Gryphon Therapeutics, Inc. |
Synthetic erythropoiesis stimulating proteins
|
|
AR025646A1
(en)
|
2000-09-13 |
2002-12-04 |
Beta Lab Sa |
RECOMBINANT METHYLOTROPHIC YEAST strain, PRODUCERS OF AN INSULIN PRECURSOR, DNA CONSTRUCTIONS AND METHOD TO OBTAIN THE CEPA.
|
|
KR100449454B1
(en)
|
2000-10-02 |
2004-09-21 |
이현철 |
Vector for Curing Diabetes Mellitus Containing Gene of Single-chain Insulin Analog
|
|
ATE270306T1
(en)
|
2000-10-02 |
2004-07-15 |
Univ Yonsei Seoul |
SINGLE CHAIN INSULIN ANALOGUES
|
|
US6436386B1
(en)
|
2000-11-14 |
2002-08-20 |
Shearwater Corporation |
Hydroxyapatite-targeting poly (ethylene glycol) and related polymers
|
|
TW593427B
(en)
|
2000-12-18 |
2004-06-21 |
Nektar Therapeutics Al Corp |
Synthesis of high molecular weight non-peptidic polymer derivatives
|
|
TWI246524B
(en)
|
2001-01-19 |
2006-01-01 |
Shearwater Corp |
Multi-arm block copolymers as drug delivery vehicles
|
|
US7105314B2
(en)
|
2001-04-02 |
2006-09-12 |
Novo Nordisk A/S |
Method for making human insulin precursors
|
|
AU2002303431C1
(en)
|
2001-04-19 |
2008-03-06 |
The Regents Of The University Of California |
Methods and composition for the production of orthoganal tRNA-aminoacyltRNA synthetase pairs
|
|
GB0113657D0
(en)
|
2001-06-05 |
2001-07-25 |
Geneprot Inc |
Improved native chemical ligation with three or more components
|
|
US20040138412A1
(en)
|
2001-09-07 |
2004-07-15 |
Paolo Botti |
Extended native chemical ligation
|
|
US6908963B2
(en)
|
2001-10-09 |
2005-06-21 |
Nektar Therapeutics Al, Corporation |
Thioester polymer derivatives and method of modifying the N-terminus of a polypeptide therewith
|
|
MXPA04004336A
(en)
|
2001-11-07 |
2005-05-16 |
Nektar Therapeutics Al Corp |
Branched polymers and their conjugates.
|
|
US7884182B2
(en)
|
2001-11-14 |
2011-02-08 |
Amylin Pharmaceuticals, Inc. |
Chemical peptide ligation with three or more components
|
|
US6716821B2
(en)
|
2001-12-21 |
2004-04-06 |
Immunogen Inc. |
Cytotoxic agents bearing a reactive polyethylene glycol moiety, cytotoxic conjugates comprising polyethylene glycol linking groups, and methods of making and using the same
|
|
CA2476425C
(en)
|
2002-02-15 |
2012-04-17 |
The Research Foundation Of State University Of New York At Buffalo |
Ribozymes with broad trna aminoacylation activity
|
|
CA2485217C
(en)
*
|
2002-05-06 |
2012-05-01 |
Thomas Jefferson University |
Insulin-associated peptides with effects on cerebral health
|
|
DE60332725D1
(en)
|
2002-05-30 |
2010-07-08 |
Scripps Research Inst |
COPPER-CATALYZED LEADING OF AZIDES AND ACETYLENES
|
|
ATE429500T1
(en)
|
2002-10-16 |
2009-05-15 |
Scripps Research Inst |
SITE-SPECIFIC INCORPORATION OF KETOAMINO ACIDS INTO PROTEINS
|
|
ES2333422T3
(en)
|
2002-10-16 |
2010-02-22 |
The Scripps Research Institute |
SYNTHESIS OF GLICOPROTEINS.
|
|
US7193035B2
(en)
|
2002-10-29 |
2007-03-20 |
Sanofi-Aventis Deutschland Gmbh |
Crystals of insulin analogs and processes for their preparation
|
|
EP1583816A4
(en)
|
2002-12-22 |
2007-06-13 |
Scripps Research Inst |
Protein arrays
|
|
CA2520750A1
(en)
|
2003-04-17 |
2004-11-04 |
The Scripps Research Institute |
Orthogonal aminoacyl-trna synthetase
|
|
US7527943B2
(en)
|
2003-07-07 |
2009-05-05 |
The Scripps Research Institute |
Compositions of orthogonal glutamyl-tRNA and aminoacyl-tRNA synthetase pairs and uses thereof
|
|
ES2301099T3
(en)
|
2003-07-07 |
2008-06-16 |
The Scripps Research Institute |
COMPOSITIONS OF LISIL-ARNT AND AMINOACIL-ARNT SYTOTASA ORTOGONAL COUPLES AND USES OF THE SAME.
|
|
EP1704242A4
(en)
|
2003-07-07 |
2008-06-18 |
Scripps Research Inst |
COMPOSITIONS OF ORTHOGONAL LEUCYL-tRNA AND AMINOACYL-tRNA SYNTHETASE PAIRS AND USES THEREOF
|
|
SG176455A1
(en)
|
2003-10-09 |
2011-12-29 |
Ambrx Inc |
Polymer derivatives
|
|
JP5697831B2
(en)
|
2003-12-03 |
2015-04-08 |
ノヴォ ノルディスク アー／エス |
Single chain insulin
|
|
US8906676B2
(en)
|
2004-02-02 |
2014-12-09 |
Ambrx, Inc. |
Modified human four helical bundle polypeptides and their uses
|
|
US7185854B2
(en)
|
2004-06-18 |
2007-03-06 |
The Boeing Company |
In-flight refueling system and method for extending and retracting an in-flight refueling device
|
|
CN105801686B
(en)
*
|
2004-07-19 |
2020-04-07 |
比奥孔有限公司 |
Insulin-oligomer conjugates, formulations and uses thereof
|
|
JP2008525473A
(en)
|
2004-12-22 |
2008-07-17 |
アンブレツクス・インコーポレイテツド |
Modified human growth hormone
|
|
SG158148A1
(en)
|
2004-12-22 |
2010-01-29 |
Ambrx Inc |
Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
|
|
CA2590429C
(en)
|
2004-12-22 |
2014-10-07 |
Ambrx, Inc. |
Compositions of aminoacyl-trna synthetase and uses thereof
|
|
EP1863840A1
(en)
*
|
2005-03-18 |
2007-12-12 |
Novo Nordisk A/S |
Pegylated single-chain insulin
|
|
KR20080026120A
(en)
|
2005-06-03 |
2008-03-24 |
암브룩스, 인코포레이티드 |
Incorporation of non-naturally encoded amino acids into proteins
|
|
CN102703446B
(en)
|
2005-08-18 |
2014-05-28 |
Ambrx公司 |
Compositions of trna and uses thereof
|
|
CA2882445A1
(en)
*
|
2005-12-14 |
2007-06-21 |
Ambrx, Inc. |
Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
|
|
US20090240029A1
(en)
*
|
2005-12-30 |
2009-09-24 |
Ambrx, Inc. |
Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and Polypeptides
|
|
CN101384711A
(en)
*
|
2006-01-19 |
2009-03-11 |
Ambrx公司 |
Non-natural amino acid polypeptides having modulated immunogenicity
|
|
CN104163864B
(en)
|
2007-03-30 |
2017-08-01 |
Ambrx公司 |
Through modifying the polypeptides of FGF 21 and its purposes
|
|
KR101383476B1
(en)
*
|
2007-11-01 |
2014-04-11 |
아스테라스 세이야쿠 가부시키가이샤 |
Immunosuppressive polypeptides and nucleic acids
|
|
JP5547083B2
(en)
*
|
2007-11-20 |
2014-07-09 |
アンブルックス，インコーポレイテッド |
Modified insulin polypeptides and their use
|